
What We're Reading: 7 Insurers Allegedly Discriminate Against Patients With HIV
What we're reading, October 18, 2016: Pfizer's Remicade biosimilar set to launch in late November; HHS receives allegations that 7 insurers are discriminating against patients with HIV; and most staff changes in the Department of Veterans Affairs are just manager moves.
Complaints filed with HHS are alleging that 7 insurers are discriminating against patients with HIV. The plans do not cover essential HIV treatment drugs or have high out-of-pocket costs for these patients, which discourages people with HIV from purchasing the plan or getting their treatment,
Pfizer’s biosimilar of Johnson & Johnson’s Remicade will be sold in late November at a 15% discount off the price of the reference product.
Most changes in staffing in the Department of Veterans Affairs (VA) since 2014 has just been the result of moving existing managers around.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.